Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy
© 2023 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy..
OBJECTIVE: This study aimed to explore the effectiveness of brivaracetam (BRV) according to baseline seizure frequency and past treatment history in subjects with focal epilepsy who were included in the Brivaracetam Add-On First Italian Network Study (BRIVAFIRST).
METHODS: BRIVAFIRST was a 12-month retrospective, multicenter study including adults prescribed adjunctive BRV. Study outcomes included sustained seizure response (SSR), sustained seizure freedom (SSF), and the rates of treatment discontinuation and adverse events (AEs). Baseline seizure frequency was stratified as <5, 5-20, and >20 seizures per month, and the number of prior antiseizure medications (ASMs) as <5 and ≥6.
RESULTS: A total of 994 participants were included. During the 1-year study period, SSR was reached by 45.8%, 39.3%, and 22.6% of subjects with a baseline frequency of <5, 5-20, and >20 seizures per month (p < .001); the corresponding figures for the SSF were 23.4%, 9.8%, and 2.8% (p < .001). SSR was reached by 51.2% and 26.5% participants with a history of 1-5 and ≥6 ASMs (p < .001); the corresponding rates of SSF were 24.7% and 4.5% (p < .001). Treatment discontinuation due to lack of efficacy was more common in participants with >20 seizures compared to those with <5 seizures per month (25.8% vs. 9.3%, p < .001), and in participants with history of ≥6 prior ASMs compared to those with history of 1-5 ASMs (19.6% vs. 12.2%, p = .002). There were no differences in the rates of BRV withdrawal due to AEs and the rates of AEs across the groups of participants defined according to the number of seizures at baseline and the number of prior ASMs.
SIGNIFICANCE: The baseline seizure frequency and the number of previous ASMs were predictors of sustained seizure frequency reduction with adjunctive BRV in subjects with focal epilepsy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
---|---|
Enthalten in: |
Epilepsia - 64(2023), 11 vom: 11. Nov., Seite 2922-2933 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lattanzi, Simona [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antiseizure medication |
---|
Anmerkungen: |
Date Revised 11.12.2023 published: Print-Electronic Citation Status In-Process |
---|
doi: |
10.1111/epi.17740 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365699667 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365699667 | ||
003 | DE-627 | ||
005 | 20231229123436.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/epi.17740 |2 doi | |
028 | 5 | 2 | |a pubmed24n1227.xml |
035 | |a (DE-627)NLM365699667 | ||
035 | |a (NLM)38079181 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lattanzi, Simona |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 11.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status In-Process | ||
520 | |a © 2023 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. | ||
520 | |a OBJECTIVE: This study aimed to explore the effectiveness of brivaracetam (BRV) according to baseline seizure frequency and past treatment history in subjects with focal epilepsy who were included in the Brivaracetam Add-On First Italian Network Study (BRIVAFIRST) | ||
520 | |a METHODS: BRIVAFIRST was a 12-month retrospective, multicenter study including adults prescribed adjunctive BRV. Study outcomes included sustained seizure response (SSR), sustained seizure freedom (SSF), and the rates of treatment discontinuation and adverse events (AEs). Baseline seizure frequency was stratified as <5, 5-20, and >20 seizures per month, and the number of prior antiseizure medications (ASMs) as <5 and ≥6 | ||
520 | |a RESULTS: A total of 994 participants were included. During the 1-year study period, SSR was reached by 45.8%, 39.3%, and 22.6% of subjects with a baseline frequency of <5, 5-20, and >20 seizures per month (p < .001); the corresponding figures for the SSF were 23.4%, 9.8%, and 2.8% (p < .001). SSR was reached by 51.2% and 26.5% participants with a history of 1-5 and ≥6 ASMs (p < .001); the corresponding rates of SSF were 24.7% and 4.5% (p < .001). Treatment discontinuation due to lack of efficacy was more common in participants with >20 seizures compared to those with <5 seizures per month (25.8% vs. 9.3%, p < .001), and in participants with history of ≥6 prior ASMs compared to those with history of 1-5 ASMs (19.6% vs. 12.2%, p = .002). There were no differences in the rates of BRV withdrawal due to AEs and the rates of AEs across the groups of participants defined according to the number of seizures at baseline and the number of prior ASMs | ||
520 | |a SIGNIFICANCE: The baseline seizure frequency and the number of previous ASMs were predictors of sustained seizure frequency reduction with adjunctive BRV in subjects with focal epilepsy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a antiseizure medication | |
650 | 4 | |a brivaracetam | |
650 | 4 | |a epilepsy | |
650 | 4 | |a focal seizures | |
700 | 1 | |a Canafoglia, Laura |e verfasserin |4 aut | |
700 | 1 | |a Canevini, Maria Paola |e verfasserin |4 aut | |
700 | 1 | |a Casciato, Sara |e verfasserin |4 aut | |
700 | 1 | |a Cerulli Irelli, Emanuele |e verfasserin |4 aut | |
700 | 1 | |a Chiesa, Valentina |e verfasserin |4 aut | |
700 | 1 | |a Dainese, Filippo |e verfasserin |4 aut | |
700 | 1 | |a De Maria, Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Didato, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Di Gennaro, Giancarlo |e verfasserin |4 aut | |
700 | 1 | |a Falcicchio, Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Fanella, Martina |e verfasserin |4 aut | |
700 | 1 | |a Ferlazzo, Edoardo |e verfasserin |4 aut | |
700 | 1 | |a Gangitano, Massimo |e verfasserin |4 aut | |
700 | 1 | |a La Neve, Angela |e verfasserin |4 aut | |
700 | 1 | |a Mecarelli, Oriano |e verfasserin |4 aut | |
700 | 1 | |a Montalenti, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Morano, Alessandra |e verfasserin |4 aut | |
700 | 1 | |a Piazza, Federico |e verfasserin |4 aut | |
700 | 1 | |a Pizzanelli, Chiara |e verfasserin |4 aut | |
700 | 1 | |a Pulitano, Patrizia |e verfasserin |4 aut | |
700 | 1 | |a Ranzato, Federica |e verfasserin |4 aut | |
700 | 1 | |a Rosati, Eleonora |e verfasserin |4 aut | |
700 | 1 | |a Tassi, Laura |e verfasserin |4 aut | |
700 | 1 | |a Di Bonaventura, Carlo |e verfasserin |4 aut | |
700 | 0 | |a BRIVAFIRST (Brivaracetam Add‐On First Italian Network Study) Group Membership |e verfasserin |4 aut | |
700 | 1 | |a Alicino, Angela |e investigator |4 oth | |
700 | 1 | |a Ascoli, Michele |e investigator |4 oth | |
700 | 1 | |a Assenza, Giovanni |e investigator |4 oth | |
700 | 1 | |a Avorio, Federica |e investigator |4 oth | |
700 | 1 | |a Badioni, Valeria |e investigator |4 oth | |
700 | 1 | |a Banfi, Paola |e investigator |4 oth | |
700 | 1 | |a Bartolini, Emanuele |e investigator |4 oth | |
700 | 1 | |a Basili, Luca Manfredi |e investigator |4 oth | |
700 | 1 | |a Belcastro, Vincenzo |e investigator |4 oth | |
700 | 1 | |a Beretta, Simone |e investigator |4 oth | |
700 | 1 | |a Berto, Irene |e investigator |4 oth | |
700 | 1 | |a Biggi, Martina |e investigator |4 oth | |
700 | 1 | |a Billo, Giuseppe |e investigator |4 oth | |
700 | 1 | |a Boero, Giovanni |e investigator |4 oth | |
700 | 1 | |a Bonanni, Paolo |e investigator |4 oth | |
700 | 1 | |a Bongiorno, Jole |e investigator |4 oth | |
700 | 1 | |a Brigo, Francesco |e investigator |4 oth | |
700 | 1 | |a Caggia, Emanuele |e investigator |4 oth | |
700 | 1 | |a Cagnetti, Claudia |e investigator |4 oth | |
700 | 1 | |a Calvello, Carmen |e investigator |4 oth | |
700 | 1 | |a Cesnik, Edward |e investigator |4 oth | |
700 | 1 | |a Chianale, Gigliola |e investigator |4 oth | |
700 | 1 | |a Ciampanelli, Domenico |e investigator |4 oth | |
700 | 1 | |a Ciuffini, Roberta |e investigator |4 oth | |
700 | 1 | |a Cocito, Dario |e investigator |4 oth | |
700 | 1 | |a Colella, Donato |e investigator |4 oth | |
700 | 1 | |a Contento, Margherita |e investigator |4 oth | |
700 | 1 | |a Costa, Cinzia |e investigator |4 oth | |
700 | 1 | |a Cumbo, Eduardo |e investigator |4 oth | |
700 | 1 | |a D'Aniello, Alfredo |e investigator |4 oth | |
700 | 1 | |a Deleo, Francesco |e investigator |4 oth | |
700 | 1 | |a DiFrancesco, Jacopo C |e investigator |4 oth | |
700 | 1 | |a Di Giacomo, Roberta |e investigator |4 oth | |
700 | 1 | |a Di Liberto, Alessandra |e investigator |4 oth | |
700 | 1 | |a Domina, Elisabetta |e investigator |4 oth | |
700 | 1 | |a Dono, Fedele |e investigator |4 oth | |
700 | 1 | |a Durante, Vania |e investigator |4 oth | |
700 | 1 | |a Elia, Maurizio |e investigator |4 oth | |
700 | 1 | |a Estraneo, Anna |e investigator |4 oth | |
700 | 1 | |a Evangelista, Giacomo |e investigator |4 oth | |
700 | 1 | |a Faedda, Maria Teresa |e investigator |4 oth | |
700 | 1 | |a Failli, Ylenia |e investigator |4 oth | |
700 | 1 | |a Fallica, Elisa |e investigator |4 oth | |
700 | 1 | |a Fattouch, Jinane |e investigator |4 oth | |
700 | 1 | |a Ferrari, Alessandra |e investigator |4 oth | |
700 | 1 | |a Ferreri, Florinda |e investigator |4 oth | |
700 | 1 | |a Fisco, Giacomo |e investigator |4 oth | |
700 | 1 | |a Fonti, Davide |e investigator |4 oth | |
700 | 1 | |a Fortunato, Francesco |e investigator |4 oth | |
700 | 1 | |a Foschi, Nicoletta |e investigator |4 oth | |
700 | 1 | |a Francavilla, Teresa |e investigator |4 oth | |
700 | 1 | |a Galli, Rosita |e investigator |4 oth | |
700 | 1 | |a Gazzina, Stefano |e investigator |4 oth | |
700 | 1 | |a Giallonardo, Anna Teresa |e investigator |4 oth | |
700 | 1 | |a Giorgi, Filippo Sean |e investigator |4 oth | |
700 | 1 | |a Giuliano, Loretta |e investigator |4 oth | |
700 | 1 | |a Habetswallner, Francesco |e investigator |4 oth | |
700 | 1 | |a Izzi, Francesca |e investigator |4 oth | |
700 | 1 | |a Kassabian, Benedetta |e investigator |4 oth | |
700 | 1 | |a Labate, Angelo |e investigator |4 oth | |
700 | 1 | |a Luisi, Concetta |e investigator |4 oth | |
700 | 1 | |a Magliani, Matteo |e investigator |4 oth | |
700 | 1 | |a Maira, Giulia |e investigator |4 oth | |
700 | 1 | |a Mari, Luisa |e investigator |4 oth | |
700 | 1 | |a Marino, Daniela |e investigator |4 oth | |
700 | 1 | |a Mascia, Addolorata |e investigator |4 oth | |
700 | 1 | |a Mazzeo, Alessandra |e investigator |4 oth | |
700 | 1 | |a Meletti, Stefano |e investigator |4 oth | |
700 | 1 | |a Milano, Chiara |e investigator |4 oth | |
700 | 1 | |a Nilo, Annacarmen |e investigator |4 oth | |
700 | 1 | |a Orlando, Biagio |e investigator |4 oth | |
700 | 1 | |a Paladin, Francesco |e investigator |4 oth | |
700 | 1 | |a Pascarella, Maria Grazia |e investigator |4 oth | |
700 | 1 | |a Pastori, Chiara |e investigator |4 oth | |
700 | 1 | |a Pauletto, Giada |e investigator |4 oth | |
700 | 1 | |a Peretti, Alessia |e investigator |4 oth | |
700 | 1 | |a Perri, Gabriella |e investigator |4 oth | |
700 | 1 | |a Pezzella, Marianna |e investigator |4 oth | |
700 | 1 | |a Piccioli, Marta |e investigator |4 oth | |
700 | 1 | |a Pignatta, Pietro |e investigator |4 oth | |
700 | 1 | |a Pilolli, Nicola |e investigator |4 oth | |
700 | 1 | |a Pisani, Francesco |e investigator |4 oth | |
700 | 1 | |a Pisani, Laura Rosa |e investigator |4 oth | |
700 | 1 | |a Placidi, Fabio |e investigator |4 oth | |
700 | 1 | |a Pollicino, Patrizia |e investigator |4 oth | |
700 | 1 | |a Porcella, Vittoria |e investigator |4 oth | |
700 | 1 | |a Pradella, Silvia |e investigator |4 oth | |
700 | 1 | |a Puligheddu, Monica |e investigator |4 oth | |
700 | 1 | |a Quadri, Stefano |e investigator |4 oth | |
700 | 1 | |a Quarato, Pier Paolo |e investigator |4 oth | |
700 | 1 | |a Quintas, Rui |e investigator |4 oth | |
700 | 1 | |a Renna, Rosaria |e investigator |4 oth | |
700 | 1 | |a Rizzo, Giada Ricciardo |e investigator |4 oth | |
700 | 1 | |a Rum, Adriana |e investigator |4 oth | |
700 | 1 | |a Salamone, Enrico Michele |e investigator |4 oth | |
700 | 1 | |a Savastano, Ersilia |e investigator |4 oth | |
700 | 1 | |a Sessa, Maria |e investigator |4 oth | |
700 | 1 | |a Stokelj, David |e investigator |4 oth | |
700 | 1 | |a Tartara, Elena |e investigator |4 oth | |
700 | 1 | |a Tombini, Mario |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Epilepsia |d 1954 |g 64(2023), 11 vom: 11. Nov., Seite 2922-2933 |w (DE-627)NLM000016195 |x 1528-1167 |7 nnns |
773 | 1 | 8 | |g volume:64 |g year:2023 |g number:11 |g day:11 |g month:11 |g pages:2922-2933 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/epi.17740 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 64 |j 2023 |e 11 |b 11 |c 11 |h 2922-2933 |